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              INTRODUCTION 
Hypertensive disorders are one of the most common medical 
complications of pregnancy. These disorders continue to be a major 
cause of maternal and perinatal morbidity and mortality worldwide.  
Pre-eclampsia is a multisystem disorder affecting the cardiovascular, 
haematological, renal, hepatic and the central nervous system, of 
which CNS involvement is the most serious complication. [1] 
Cerebrovascular involvement is the direct mechanism of 
death in 40% of these patients. [2] 
When promptly recognised and treated, symptoms and 
radiological changes can be reversed. In some women it can 
progress to ischemia, massive infarction and death.  
Besides clinical presentation, Neuroimaging is the only mode 
to assess the CNS involvement.  Neuroimaging gives a more accurate 
assessment of the degrees of CNS involvement in these cases. [3] 
Vascular changes in organs that occur during pregnancy have 
been the subject of intense study. Understanding how pregnancy and the 
  
 
 
postpartum state affect the structure & function of the cerebrovascular 
bed may provide important clues as to how eclampsia develops and to 
potential treatments of this devastating condition.  
To identify the prevalence of neurovascular complications 
and neurovascular changes in Eclampsia a prospective descriptive 
study was conducted in Institute of Obstetrics and Gynaecology, 
Madras Medical College, Chennai. CT scan Brain was done for 100 
patients of eclampsia and the findings were analysed.   
  
 
 
REVIEW OF LITERATURE 
Hypertension is one of the most common medical 
complications that affect both fetal and maternal health and is often 
life threatening. Multiple maternal organs are affected by 
hypertension in pregnancy including brain in the form of eclampsia.  
Eclampsia is a leading cause of maternal death, with classical 
neurological symptoms that include headache, nausea, vomiting, 
cortical blindness, coma and convulsions.  
It is well known that pregnancy is associated with significant 
cardiovascular adaptation of both local and systemic circulation. 
The changes in cerebral blood flow autoregulation and 
cerebrovascular resistance enhance BBB permeability and 
hydrostatic brain edema.  
DEFINITION 
Eclampsia is defined as seizures that cannot be attributed to 
other causes in a woman with pre-eclampsia. [4] 
Pre-eclampsia is defined as a rise in diastolic B.P of 90mm of 
Hg or more or systolic BP of 140mm of Hg or more recorded on at 
  
 
 
least two occasions six hours apart and the development of 
proteinuria of 300mg or more in 24 hours or presence of 30mg or 
more per decilitre in random urine samples.  
CLASSIFICATION 
NATIONAL HIGH BLOOD PRESSURE EDUCATION 
PROGRAM WORKING GROUP (2000)[5] 
GESTATIONAL HYPERTENSION 
 BP >/= 140/90 mm of Hg for first time during pregnancy.  
 No proteinuria.  
 BP returns to normal < 12 weeks postpartum.  
 Final diagnosis made postpartum.  
 May have other signs and symptoms of pre-eclampsia 
for example, epigastric discomfort or thrombocytopenia.  
PRE-ECLAMPSIA 
Minimum criteria 
 BP >/=140/90mm of Hg after 20 weeks gestation.  
 Proteinuria>/=300mg/ 24 hours or >/= 1+ dipstick 
  
 
 
Increased certainty of Pre-eclampsia 
 BP >/= 160/100mm of Hg 
 Proteinuria 2gm/24 hours or 2+ dipstick.  
 Serum creatinine > 1.2mg/dl unless known to be 
previously elevated.  
 Platelets < 1, 00, 000/mm3 
 Microangiopathic hemolysis (increased LDH) 
 Elevated ALT or AST 
 Persistent headache or other cerebral or visual disturbances.  
 Persistent epigastric pain.  
ECLAMPSIA 
Seizures that cannot be attributed to other causes in a woman 
with pre-eclampsia.  
SUPER IMPOSED PRE-ECLAMPSIA  
(ON CHRONIC HYPERTENSION) 
 New onset proteinuria >/=300mg/24 hrs in hypertensive 
women but no proteinuria before 20 weeks gestation.  
  
 
 
 Sudden increase in proteinuria or blood pressure or 
platelet count <1,00,000/mm3 in women with 
hypertension and proteinuria before 20 weeks gestation.  
CHRONIC HYPERTENSION 
 BP > 140/90 mm Hg before pregnancy or diagnosed 
before 20 wks gestation not attributable to gestational 
trophoblastic disease.  
Or 
 Hypertension first diagnosed after 20 weeks gestation 
and persistent after 12 weeks postpartum.  
PROTEINURIA 
  Proteinuria is an important sign of pre-eclampsia. It reflects 
the degree of glomerular damage that causes leakage of protein 
through the basement membrane. The amount of proteinuria is used 
as an indicator for assessing the severity of pre-eclampsia. 
Significant proteinuria is described as 300mg per litre or more of 
urinary protein loss in 24 hours or persistent 30mg/dl (1+ dipstick) 
in random clean catch sample on at least 2 occasions collected 6 
hours apart.  
  
 
 
Dipsticks are routinely used to measure proteinuria and the 
colour changes correspond to  
PROTEIN  
Trace – 0. 1gm/L 
1+  - 0. 3gm/L 
2+  - 1. 0gm/L 
3+  - 3. 0gm/L 
4+  - 10gm/L 
INCIDENCE 
 The incidence of pre-eclampsia is 7-10% depending on the 
population studied. The incidence of eclampsia in Institute of 
Obstetrics and Gynaecology, Chennai is 1%. Worldwide 
approximately 50,000 women are estimated to die annually because 
of eclampsia. The overall maternal death rate of eclampsia is 2% 
but varies geographically according to the available healthcare 
system. The perinatal mortality among babies born to eclamptic 
mother was 32.7% compared to 10.5% for total perinatal mortality. 
[6] 
  
 
 
PATHOPHYSIOLOGY 
Pre Eclampsia / Eclampsia is now considered to be primarily 
a placental disorder. Both poor placentation as well as hyper 
placentosis (e. g twin / molar pregnancies) is associated with this 
condition [22]. It is believed that either an unknown factor (factor 
X, as some call it) or villous debris from the malformed placenta 
manages to reach the maternal circulation, eliciting an 
immunological response from the mother’s system [33]. Other 
variables like dietary factors namely protein and caloric 
deficiencies, lack of essential fatty acids, deficiencies of 
magnesium, calcium, zinc and an excess of sodium as well as 
genetic factors like abnormal alleles for the genes of TNF- alpha, 
angiotensinogen, Factor V and nitricoxide synthase[NOS] 
predispose to this event [23-26]. The maternal response is primarily 
immunological with increased activation and functional 
abnormalities of maternal neutrophils, high circulating levels of the 
cell adhesion molecule VCAM-1 and occurrence of immune 
complexes in the placenta, maternal serum and various organs [27, 
28]. The effect of this maternal response is widespread cellular 
dysfunction with multisystem involvement [29]. There is 
  
 
 
endothelial change with increased capillary permeability raised 
fibronectin levels and electro microscopic evidence of damaged 
endothelium [30, 31]. Coagulation abnormalities occur caused by 
increased activation and consumption of platelets, low antithrombin 
III levels, abnormal prostaglandin metabolism and in a few cases 
florid DIC[32]. These pathophysiological changes lead to 
hypertension, edema, proteinuria, bleeding tendencies, renal 
dysfunction, liver damage and the neurological abnormalities.  
The brain is normally protected from extremes of blood 
pressure by an autoregulation system that ensures constant 
perfusion over a wide range of systemic pressures, in response to 
the systemic hypotension, cerebral arterioles dilate to maintain 
adequate perfusion. Whereas vessels constrict in response to high 
pressures. Above the upper limit of auto regulation, hypertensive 
encephalopathy may occur [7].  
Two theories have been proposed to account for the clinical 
and radiological abnormalities associated with these cases. The first 
theory postulates that hypertensive encephalopathy results from 
spasm of cerebral vasculature in response to acute hypertension 
  
 
 
(i.e. over regulation), resulting in ischaemia and cytotoxic edema 
involving mainly the border – zone arterial regions [8, 9].  
A more recent hypothesis suggests that the syndrome results 
from breakthrough of auto regulation with passive over distension 
of cerebral arterioles [10, 11]. This would result in interstitial 
extravasation of protein and fluid producing focal vasogenic 
(hydrostatic) edema in peripheral vascular distribution of the 
involved vessel.  
Belfort and associates (1999) found that pre-eclampsia was 
associated with increased cerebral perfusion pressure counter 
balanced by increased cerebrovascular resistance with no net 
change in cerebral blood flow [12].  
In eclampsia, presumably due to loss of auto regulation of 
cerebral blood flow, there was hyper perfusion similar to that seen 
in hypertensive encephalopathy, unrelated to pregnancy. Women 
with headache frequently have increased cerebral perfusion.  
Apollon and co-workers 2000, Cunningham and twickler 
2000 concluded that eclampsia is caused by transient loss of 
  
 
 
cerebral auto regulation. This is supported by the evidence of 
widespread hypodense areas confirmed by CT and MRI studies [13, 
14].  
Importantly Morris 1997, Rutherford 2003, Zeeman 2004b 
and all associates have not identified cerebral vasospasm [15, 16, 17].  
Zeeman et al found in normal pregnancy cerebral blood flow 
decreases beginning early in pregnancy and is 20 percent less than 
non pregnant value by late pregnancy. Subsequently their 
investigations showed that with pre-eclampsia there is 
hyperperfusion which contribute to vasogenic edema which they 
identified using MRI. 
The susceptibility of posterior circulation to the lesions is a 
well known [18, 19] but a poorly understood phenomenon, but one 
likely explanation involves the regional heterogeneity of the 
sympathetic vascular innervations.  
In experimental studies, the sympathetic innervation of the 
intracranial arterioles has been shown to protect the brain from 
marked blood pressure [20]. Moreover, ultra structural studies have 
  
 
 
shown that the internal carotid system is much better supplied with 
sympathetic innervations than in the vertebrobasilar system [21]. 
Acute hypertension would in this view stimulate the perivascular 
sympathetic nerves, which would protect the anterior but not the 
more poorly innervated posterior circulation. This would result in 
breakthrough of auto regulation with edema mainly in the occipital lobes.  
Pregnancy and the post partum state also appear to affect 
endothelial vasodilator production and smooth muscle reactivity. 
Cerebral arteries from late pregnant and post partum animals 
constrict in a concentration dependent manner to serotonin, whereas 
arteries from non-pregnant animals dilate[2]. Because the dilatation 
was in the presence of both cyclo oxygenase and NO inhibition, 
there results suggest that arteries from non-pregnant animals 
produce endothelium dependent hyperpolarising factor in response 
to serotonin that is not present in arteries during pregnancy or the 
post partum state that are more dominated by NO. The significance 
of this change of vasodilator production by the cerebral 
endothelium is unclear; however it is possible that these changes 
  
 
 
contribute to hemodynamic alteration during pregnancy similar to 
the periphery.  
ANATOMICAL PATHOLOGY 
There are 2 distinct types of cerebral pathology based on 
hypertension. The first is gross haemorrhage due to ruptured 
arteries caused by severe hypertension. Pre-eclampsia is not 
necessary for their development. The second type of cerebral lesion 
seen with eclampsia is a more widespread, focal and seldom fatal 
lesion. They are edema, hyperaemia, ischemia, thrombosis and 
haemorrhage.  
Sheehan (1950) found haemorrhage ranging from petechiae to 
gross bleeding in 56 percent of the brains of 48 women with 
eclampsia, he examined very soon after death. In addition he reported 
that if the brain were examined within an hour after death, they most 
often displayed normal firmness without obvious edema [34].  
In “Pathology of Toxemia of pregnancy” various histological 
features of autopsy findings in the brain of women with eclampsia 
were described. 
  
 
 
 They are  
1. Pia arachnoid haemorrhage  
2. Medium – sized haemorrhage in outer white matter 
3. Sub cortical haemorrhage  
4. Basal ganglia haemorrhage 
5. Multiple focal softening (or) petechiae 
6. Large haemorrhage in white matter 
7. Cortical Petechiae 
NEUROIMAGING STUDIES 
Zeeman and colleagues (2004 a) reported that nearly all 
women with Eclampsia have abnormal brain findings [36].  
Various techniques used for neuroimaging in eclampsia are 
Computed Tomography scanning of brain, Magnetic Resonance 
Imaging of the brain (MRI), Magnetic Resonance (MR) 
angiography, Magnetic Resonance (MR) Venography, Cerebral 
angiography, Transcranial Doppler study, Single Photon Emission 
Computed Tomography (SPECT).  
  
 
 
Of these most common and most useful techniques are the CT 
scan of brain and MRI of brain. Other modalities such as MR 
angiography findings may be normal or may show reversible 
cerebral vasospasm.  
MR venography findings are usually normal and are helpful 
in excluding the possibility of dural sinus thrombosis, an important 
differential diagnosis.  
Cerebral angiography shows focal/segmental cerebral 
vasoconstriction. The venous phase of the study also helps to show 
normal flow pattern in dural sinuses helping to exclude sinus 
thrombosis.  
Transcranial doppler study is a research tool used in the 
evaluation of eclampsia. It shows an increased velocity of blood 
flow in the middle cerebral artery, which is reversible. The change 
tends to parallel the severity of the clinical syndrome [37].  
SPECT scanning reveals perfusion deficits [38].  
Characteristic findings in MRI of the brain are hyper intense 
lesion on T2 – weighted, Fluid Attenuation Inversion Recovery 
  
 
 
(FLAIR) or proton weighted sequences affecting the white matter 
and adjacent grey matter of the occipital / parietal lobes. However 
deep white matter structures, basal ganglia and white matter of the 
frontal or temporal lobes and brain stem can also be affected [39, 40].  
Characteristic CT scan findings are 
1. Normal 
2. Cerebral edema 
3. Diffuse white matter low density areas 
4. Patchy area of low density 
5. Occipital white matter edema 
6. Loss of normal cortical sulci 
7. Reduced ventricular size 
Cerebral haemorrhage   
1. Intraventricular haemorrhage 
2. Parenchymal haemorrhage (high density ) 
3. Cerebral infarction 
  
 
 
4. Low attenuation areas 
5. Basal ganglia infarction 
Posterior Reversible Encephalopathy Syndrome (PRES) is a 
potentially devastating neurologic syndrome characterised by 
rapidly progressive signs and symptoms which includes headache, 
seizures, consciousness disturbance and (or) visual disturbances. 
Imaging abnormalities of PRES are predominantly in bilateral 
posterior circulation regions mainly in the parieto – occipital areas. 
When unrecognised the patient’s condition can progress to 
ischemia, massive infarction and death. Alternative term such as 
hypertensive encephalopathy, reversible posterior cerebral edema 
syndrome and posterior reversible leuko encephalopathy are used to 
describe this group of disorder [42]. A variety of causes such as 
pre-eclampsia / eclampsia, uremia, systemic lupus erythematosus 
(SLE) and immuno suppressant therapy have been associated with 
this syndrome [41-43].  
Schwartz et al (1992) [44] used CT, MR imaging and SPECT 
imaging in 14 cases with hypertensive encephalopathy. 8 cases 
were obstetric patients, all with Pre-eclampsia – eclampsia 
  
 
 
syndrome. All had abnormalities in the occipital lobes bilaterally 
involving the sub cortical white matter and often extending to the 
cortical surface. These lesion appeared hypo dense in CT. 
Additional abnormalities were noted bilaterally at the parieto 
occipital junction (three patients), cerebellum (two patients), 
superior frontal lobes (two patients), and left basal ganglia (one 
patient). Abnormalities in the occipital lobes were the most 
significant both radiologically and clinically. One patient with 
thrombocytopenia had evidence of an associated small 
haemorrhage. In no patient was an infarct or haematoma shown. 
The abnormalities in all patients resolved within 1-2 weeks after 
blood pressure was controlled at which time all neurologic signs 
and symptoms resolved completely without sequelae.  
Chakravarthy et al (2000) [3] studied 19 patients with 
Eclampsia. All patients had recurrent generalised seizures. 
Neuroimaging (CT and or MRI) revealed symmetrical occipital 
lesion in all. One patient had a large pontine lesion. All patients 
recovered fully without any residual neurological deficit and 
radiological lesion resolved completely in all except one case. 
  
 
 
Seizure control was achieved in all patients with intravenous 
phenytoin.  
Dejana Jovanovic et al (1999)[45] investigated 31 women 
with Eclampsia in a 11 year period. CT scan brain was done for 29 
patients and the pathological findings were discovered in 83% of 
patients. The most common findings were bilateral multifocal 
cerebral odema usually in occipital and posterior parts of parietal 
lobes. In all patients the odema resolved or regressed during two 
weeks of follow up.  
Moodley et al (1993) [46] found that the most common CT 
scan findings associated with Eclampsia were transient reversible 
subcortical white matter hypodensities indicative of odema, and in 
the absence of clinical signs, central nervous system pathology did 
not alter the management.  
Drislane and Wang (1997) [47] reported that CT 
abnormalities in eclamptics were not always benign and reversible 
and preceded long term neurological sequelae.  
  
 
 
Mei-chun chou et al [48] reviewed 12 cases of PRES and 
described the imaging findings using MRI & Diffusion weighted 
imaging (DWI). PRES lesions were typically located in the 
territories of the posterior circulation, mainly in the parieto- 
occipital and posterior temporal region with white matter 
predominance. Only one patient had Eclampsia. MRI of that patient 
revealed bilateral occipital lobe involvement with white matter 
predominance over grey matter.  
Cunningham F. Gary et al [49] studied the clinical course of 
15 women with pre-eclampsia or eclampsia complicated by 
blindness .13 women underwent computed tomography, of them 8 
had low-density areas predominantly in the occipital lobes. 5 out of 
these 13 patients subsequently underwent magnetic resonance 
imaging showed corresponding hyperintense lesion in the occipital 
areas. The conclusion was that cortical blindness associated with 
pre-eclampsia - eclampsia results from petechial haemorrhages and 
focal odema in the occipital lobes.    
  
 
 
 AIM OF THE STUDY 
1. To analyse the findings of CT scan of brain in 
eclampsia.  
2. To determine if these findings can be of value in 
determining the prognosis of this disorder and whether 
it adds to the understanding of the pathogenesis of this  
disorder. 
3. To identify the prevalence of neurovascular 
complications in these cases.  
  
 
 
MATERIALS AND METHODS.  
TYPE OF STUDY 
Prospective  descriptive study.  
PERIOD OF STUDY  
August 2008 to August 2009.  
SETTING 
The study was conducted at INSTITUTE OF OBSTETRICS 
AND GYNAECOLOGY, EGMORE, CHENNAI. The study was 
approved by the Board of Ethical committee.  
SAMPLE SIZE 
Sample size – 100 
METHODOLOGY 
Screening 
  All patients in intensive care unit with a provisional 
diagnosis of Eclampsia were screened for enrolment into the study.  
SUBJECT SELECTION CRITERIA 
Inclusion criteria 
Patients with eclampsia 
  
 
 
Exclusion criteria 
Patients with known history of  
 Chronic hypertension alone 
 Epilepsy 
 Cerebral tumours 
 Renal disorders.  
CONSENT 
Informed consent in the form of written consent was obtained 
from the patients or relatives (in situations where patients is 
indisposed) after explaining the procedure.  
PROTOCOL 
This study was conducted in intensive care unit, postoperative 
ward and complicated postnatal ward.  
Patient’s medical history, obstetric history with complication, 
demographic details as detailed in preformed proforma was obtained. 
CT scan brain was done within 1 week in the postpartum period.  
  
 
 
FOLLOW- UP 
Patients with positive findings in the CT scan brain were 
followed up after  2 months.  
  
 
 
DATA ANALYSIS AND RESULTS 
Computerised tomographic scan of brain was taken for 100 
patients with eclampsia. The CT scan findings and the data 
collected from these 100 patients were analysed. When comparison 
was done between the patients with positive CT scan findings and 
patients with negative CT findings Chi-square test was used for 
statistical analysis.  
Table – 1: AGE DISTRIBUTION 
AGE IN YEARS N=100 % 
<20  15 15% 
20 – 30 78 78% 
>30  7 7% 
 The most common age group in our study was in the range of 
20 to 30 years.  
78% of the patients were in the age group of 20 to 30 years. 
Only 7% were in the age group of more than 30 years.  
  
 
 
TABLE – 2: PARITY 
PARITY N= 100 % 
Primi 68 68% 
G2 21 21% 
G3 9 9% 
G4 2 2% 
Primigravida constituted the majority in our study. 68% of the 
patients were primigravida.  
Table – 3: BODY MASS INDEX 
BODY MASS INDEX N=100 % 
< 19. 8 4 4% 
19. 8-26 69 69% 
26-29 17 17% 
>29 10 10% 
Majority of the patients had a normal body mass index of   
19.8 to 26. 
  
 
 
69% of the patients in our study had a BMI of 19.8 to 26. 
10% of patients had BMI of more than 29.  
Table – 4: Gestational Age at Presentation 
GESTATIONAL AGE IN WEEKS N=100 % 
20-28 7 7% 
29-36 42 42% 
37-40 24 24% 
Postpartum 27 27% 
Most of the patients were in the antenatal period at the time 
of presentation. 42% of the patients were in the gestational age of 
29 to 36 weeks. 27% of the patients were in the postpartum period.  
Table – 5: Duration of Hypertension since Diagnosis 
DURATION IN WEEKS N=100 % 
0 (At presentation) 75 75% 
</=4 19 19% 
5-12 5 5% 
13-20 1 1% 
  
 
 
In our study 75% of the patients with eclampsia had 
hypertension diagnosed only at the time of presentation. Only 1% 
of patient had hypertension for more than 13 weeks.  
Table – 6: IMMINENT SYMPTOMS 
IMMINENT SYMPTOMS N=100 % 
Present 73 73% 
Absent 27 27% 
73% of patients had imminent symptoms.  In 27% of patients 
there were no imminent symptoms.  
Table – 7: HAEMOGLOBIN MEASUREMENT 
HB IN GMS% N=100 % 
>/=11 14 14% 
10 -10. 9 22 22% 
7 – 10 62 62% 
4 – 7 2 2% 
62% of patients with eclampsia in our study had Hb% in the 
range of 7 to 10gms%.  
14% of patients had Hb% above 11gms%.  
  
 
 
 
Table -8: CONVULSIONS 
CONVULSIONS N= 100 % 
ANTEPARTUM ECLAMPSIA
1 
2 
3 
>/=4 
69 
21 
18 
16 
14 
69% 
POSTPARTUM ECLAMPSIA 
1 
2 
3 
>/=4 
36 
22 
6 
6 
2 
36% 
BOTH 5 5% 
In our study 69% of patients had antepartum eclampsia. Out 
of 69 patients 14 had 4 or more convulsions.  36% of patients had 
postpartum eclampsia. Out of the 36 patients 2 had 4 or more 
convulsions. 5% of patients had both antepartum and postpartum 
eclampsia.  
  
 
 
Table - 9: CT SCAN FINDINGS 
Out of 100 eclamptic patients 15 patients had positive 
findings in the CT scan brain.  
Table – 10: POSITIVE PAST HISTORY 
POSITIVE 
PAST 
HISTORY 
NEGATIVE CT 
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
NO 83 97.6% 13 86.7%
YES 2 2.4% 2 13.3%
p – 0. 045 significant 
97.6% in the negative CT findings group and 86.7% in the 
positive findings group had no positive past history.  13.3% in the 
positive findings group and 2.4 % in the negative CT findings 
group had past history of eclampsia or thrombocytopenia.  
FINDINGS N = 100 
NORMAL 85 
ABNORMAL 15 
  
 
 
Table – 11: CONSCIOUS LEVEL 
CONSCIOUS 
LEVEL 
NEGATIVE CT 
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
Conscious 68 80% 7 46.7%
Drowsy 17 20% 3 20% 
Unconscious 0 0 5 33.3%
p – 0. 000 significant 
33.3% of patients in the positive CT findings group & none in 
negative CT findings group were unconscious at the time of 
presentation.  
 
 
 
 
 
 
  
 
 
Table – 12: BLOOD PRESSURE PARAMETERS 
Systolic BP    p value – 0.371 
Diastolic BP  p value  – 0.088 
MAP              p value – 0.568  
p value were not significant.  
BLOOD PRESSURE 
PARAMETERS 
NEGATIVE C
T 
FINDINGS 
GROUP 
% POSITIVE CT
FINDINGS 
GROUP 
% 
Systolic BP(mm of Hg) 
<140 
140 – 160 
161 – 200 
>200 
 
3 
48 
33 
1 
 
3.5% 
56.5%
38.8%
1.2% 
 
0 
12 
3 
0 
 
0 
80% 
20% 
0 
Diastolic BP(mm of Hg)
90 – 100 
100 – 110 
>110 
 
31 
29 
25 
 
36.5%
34.1%
29.4%
 
10 
3 
2 
 
66.7%
20% 
13.3%
MAP (mm of Hg) 
96 -116 
116 -126 
>126 
 
24 
23 
38 
 
28.2%
27.1%
44.7%
 
4 
6 
5 
 
26.7%
40% 
33.3%
  
 
 
56.5% in negative CT findings group & 80% in positive CT 
findings group had systolic BP in the range of 140 – 160 mm of Hg.  
None in the positive CT finding group had systolic BP <140 
or >200mm of Hg. 44.7% in negative CT findings group & 33.3% 
in positive CT finding group had MAP >126mm of hg.  
Table – 13: FUNDUS CHANGES  
FUNDUS 
CHANGES 
NEGATIVE CT 
FINDINGS 
GROUP 
% 
POSITIVE CT 
FINDINGS 
GROUP 
% 
NORMAL 77 90.6% 11 73.3%
GRADE-1 7 8.2% 0 0 
GRADE-2 1 1.2% 1 6.7% 
GRADE-3 0 0 2 13.3%
OTHERS 0 0 1 6.7% 
p – 0.000   significant 
Grade -3 fundus changes were seen in 13.3% of patients in 
positive CT findings group and none in negative CT findings group. 
90.6% in negative CT findings group had normal fundus.  
  
 
 
Table – 14: PROTEINURIA 
PROTEINURIA NEGATIVE 
CT 
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
1+ 
2+ 
3+ 
4+ 
33 
26 
15 
11 
38.8%
30.6%
17.6%
12.9%
3 
11 
1 
0 
20% 
73.3%
6.7% 
0 
p – 0.015    significant. 73.3% of patients in positive CT 
findings group and 30.6% in negative CT findings group had 
proteinuria of 2+.  
Table – 15: PLATELET COUNT 
PLATELET 
COUNT 
Lakhs/cu mm 
NEGATIVE CT 
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
< 1 
 
1 – 4. 5 
0 
 
85 
0 
 
100%
3 
 
12 
20%
 
80%
p – 0.000   significant 
  
 
 
20% in positive CT findings group & none in negative CT 
findings group had platelet count less than 1 lakh/mm3.  
Table – 16: LIVER FUNCTION TEST 
LFT NEGATIVE CT 
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
NORMAL 
 
ALTERED 
84 
 
1 
98.8%
 
1.2% 
12 
 
3 
80%
 
20%
p – 0.001 significant. 20% in positive CT findings group & 
1.2% in negative CT group had altered liver function test.  
Table – 17: RENAL FUNCTION TEST 
RFT NEGATIVE CT 
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
NORMAL 
 
ALTERED 
84 
 
1 
98.8%
 
1.2% 
15 
 
0 
100%
 
0 
p – 0.673   not significant 
Only 1.2% in negative CT group & none in positive group 
had altered renal function test.  
  
 
 
Table – 18: MAGNESIUM SULPHATE REGIMEN 
p – 0.006   significant. Only in positive CT group 13.3% were 
treated with MgSo4 infusion. 73.3% in positive CT group & 71.87% 
in negative CT group were treated with standard dose regimen.  
Table – 19 ANTICONVULSANT 
PHENYTOIN NEGATIVE CT 
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
YES 
 
NO 
    30 
 
    55 
35.3%
 
64.7%
     11 
 
      4 
73.3%
 
26.7%
p – 0.006      significant 
73.3% in positive CT group & only 35.3% in negative CT 
group were treated with phenytoin in addition to MgSo4 regimen.  
MGSO4 NEGATIVE CT
FINDINGS 
GROUP 
% POSITIVE CT 
FINDINGS 
GROUP 
% 
LOW DOSE 22 25.9% 2 13.3%
STANDARD 
DOSE 
61 71.8% 11 73.3%
INFUSION 0 0 2 13.3%
NOT GIVEN 2 2.4% 0 0 
  
 
 
Table – 20: TYPE OF CT CHANGES 
CT CHANGES        N = 100    % 
NORMAL 
 
CEREBRAL ODEMA 
 
HAEMORRHAGE 
 
INFARCTION 
 
NOT RELATED 
        85 
   
        7 
 
        5 
 
        2 
 
        1   
85% 
 
7% 
 
5% 
 
2% 
 
1% 
 85% of patients with eclampsia had normal CT scan findings. 
Cerebral odema was the most common finding in the positive CT 
findings group.  Out of 15 women 7 had cerebral odema. Next 
common finding was cerebral haemorrhage (5). 2 patients had 
cerebral infarction. 1 patient had an unrelated finding i.e. old 
calcified lesion in parietal region.  
 
 
 
 
  
 
 
 
Table – 21: AREAS OF BRAIN AFFECTED 
  AREAS         N = 15   %  
DIFFUSE 
 
FRONTO-TEMPORAL 
 
PARIETAL 
 
OCCIPITAL 
 
BRAINSTEM  
4 
 
2 
 
6 
 
2 
 
1 
26.6% 
 
13.3% 
 
40% 
 
13.3% 
 
6.6% 
Parietal region of the brain was the most affected. 6 (40%) 
patients had lesion in the parietal region. 4(26.6%) patients had 
diffuse involvement of the brain. 2(13.3%) patients had fronto-
temporal region involvement. 2(13.3%) patients had occipital lobe 
involvement. 1(6.6%) patient had brain stem lesion.  
 
 
 
  
 
 
 
Table – 22: MATERNAL OUTCOME 
MATERNAL 
OUTCOME 
NEGATIVE 
CT 
FINDING 
GROUP 
% POSITIVE 
CT 
FINDING 
GROUP 
% 
RECOVERED 
 
RECOVERED 
WITH SEQUELAE 
 
EXPIRED 
85 
 
0 
 
 
0 
100%
 
0 
 
 
0 
7 
 
1 
 
 
7 
46.7%
 
6.7% 
 
 
46.7%
p – 0.000   significant 
All patients who did not have any significant findings in the 
CT scan brain taken recovered fully. 46.7% of patients in positive 
CT finding group recovered. Another 46.7% in positive CT finding 
group expired. 1(6.7%) patient in positive CT finding group 
recovered with sequelae.  
 
  
 
 
 
Table – 23: COMPARISON OF MATERNAL RECOVERY 
WITH TYPES OF CT CHANGES 
Types Recovered % Recovered 
with 
sequelae 
% Expired % 
NORMAL 
 
CEREBRAL ODEMA
 
HAEMORRHAGE 
 
INFARCTION 
 
NOT RELATED 
    85 
 
    6 
 
    0 
 
    0 
 
    1 
100%
 
85.7%
 
0 
 
0 
 
100%
     0 
 
     0 
 
     0 
 
     1 
 
     0 
0 
 
0 
 
0 
 
50% 
 
0 
   0 
 
   1 
 
   5 
 
   1 
 
   0 
0 
 
14.2%
 
100%
 
50% 
 
0 
p <0.05   significant 
All 5 patients i.e. 100% who had haemorrhage in brain 
expired.1 out of 2 patients i.e. 50% who had infarction in brain 
expired and the other patient with infarction in brain recovered with 
hemiparesis. 6 out of 7 patients i.e. 85.7% who had cerebral odema 
recovered.1 patient i.e. 14.2% with cerebral odema expired. 1 
patient who had old calcified lesion in the brain recovered.  
  
 
 
Table – 24: COMPARISON OF MATERNAL RECOVERY 
WITH AREAS AFFECTED 
Areas Recovered % Recovered 
with 
Sequelae 
% Expired % 
DIFFUSE 
 
FRONTO- 
TEMPORAL 
 
PARIETAL 
 
OCCIPITAL 
 
BRAINSTEM 
    4 
 
    0 
 
 
    2 
 
    1 
 
    0 
100%
 
0 
 
 
33.3%
 
50% 
 
0 
     0 
 
     0 
 
 
     1 
 
     0 
 
     0 
0 
 
0 
 
 
16.7% 
 
0 
 
0 
   0 
 
   2 
 
 
   3 
 
   1 
 
   1 
0 
 
100%
 
 
56% 
 
50% 
 
100%
 p – 0. 000    significant 
All 4 patients i.e. 100% with diffuse involvement recovered. 
Both of the 2 patients i.e. 100% with lesion in fronto-temporal 
region expired. Out of 6 patients with parietal lobe involvement 2 
patients i.e. 33.3% recovered, 1 patient i.e. 16.7% recovered with 
hemi paresis, 3 patient i.e. 56% expired. Out of the 2 patients with 
occipital lobe involvement 1 patient i.e. 50% recovered, 1 patient 
i.e. 50% expired. 1 patient who had brainstem involvement expired.  
  
 
 
Table – 25: FOLLOW – UP IN ALIVE POSITIVE CT 
FINDINGS GROUP 
FOLLOW-UP N=8 % 
LESION DISAPPEARED 6 75% 
LESION PERSISTED 1 12.5% 
LOST FOLLOW-UP 1 12.5% 
Out of 8 patients who were alive in the positive findings 
group, lesion disappeared in 6 i.e. 75%. In 1 patient i.e. 12.5% 
lesion persisted. 1 patient lost follow-up.  
  
 
 
DISCUSSION 
In this study 100 women with eclampsia were selected 
according to the inclusion exclusion criteria and Computed 
Tomographic Scan of brain was done.  The findings obtained were 
analysed.  
In our study (Table -1) the most common age group was 20 to 
30 yrs. 78% of patients were in the age group of 20 to 30yrs. 7% of 
patients were above 30yrs of age. 15% of patients were below 20yrs 
of age.  
 In our study (Table-2) majority of the patients were 
primigravida. 68% of patients were primigravida.  
 In the study by Milliez et al [50] majority of the patients 
were multiparas.  
In our study (Table-3) 69% of patients had body mass index 
in the range of 19.8 – 26. That is majority of the patients had 
normal body mass index. 10% of patients were obese with BMI 
greater than 29.4% of patients had low BMI of less than 19.8.  
  
 
 
In our study (Table-4) majority of the patients were in the 
antepartum period at the time of presentation. 27% of patients were 
in the postpartum period at the time of presentation. Majority of the 
patients (42%) were in the gestational age group of 29 to 36 weeks.  
In our study (Table-5) majority had HT diagnosed at the time 
of presentation i.e. 75% of patients had HT diagnosed only at the 
time of presentation with eclampsia.  
     In the study by Chakravarthy et al also, all patients except one 
did not show any evidence of pre-eclampsia till the last clinical 
visit.  
This observation highlights the magnitude of undiagnosed 
preeclampsia and also the need for screening and effective 
treatment.   
In our study (Table-6) majority of the patients (73%) had 
imminent symptoms of headache, vomiting, epigastric pain, 
blurring of vision, or decreased urine output. 27% of patients had 
no imminent symptoms.  
  
 
 
In our study (Table-7) majority of the patients were anaemic. 
62% of patients had Hb% in the range of 7-10 gms%. Only 14% of 
patients had Hb% greater than 11gms.  
 In our study (Table-8) majority of the patients (69%) had 
antepartum eclampsia. 36% of patients had postpartum eclampsia. 
5% of patients had both antepartum and postpartum eclampsia. 16 
patients had 4 or more convulsions.  
In our study (Table -9) 15 patients i.e.15% had positive CT 
scan findings, remaining 85 patients had normal finding.  
According to a study conducted by Dejana Jovanovic et al 
[45] CT scan brain was done for 29 women with Eclampsia in a 11 
year period and pathological findings were discovered in 83% of 
patients.  
In a study conducted by Milliez j et al [50] CT scan brain was 
done for 44 women with Eclampsia, 18(40%) had pathological 
abnormalities in CT scan.  
In a study conducted by Chakravarthy et al [3] 19 patients 
with Eclampsia were analysed in a 3 year period. But in this CT or 
  
 
 
MRI was used. All had recurrent generalised seizures. All had 
radiological brain lesion.  
The main difference between these studies and our study is 
that, our study was a prospective study done in a 1 year period. 
Almost 70% of patients with eclampsia admitted to our hospital 
were included in the study to find out the prevalence of CT scan 
abnormalities in these patients.  
In order to find out the prognosis and associated factors, 
patients were divided into 2 groups based on the positive or 
negative CT findings and the results obtained were compared and 
analysed.   
In our study (Table-10) 13.3% in the positive CT group & 
none in negative group had positive past of Eclampsia or 
thrombocytopenia with the p value of < 0.05 which is statistically 
significant difference was observed between the groups in terms of 
positive past history.This indicates the severity and recurrence of 
preeclampsia and eclampsia.  
  
 
 
In our study (Table-11) 33.3% of patients in positive CT 
findings group and none in negative CT group were unconscious at 
the time of presentation with p value of 0.000 which is statistically 
significant .  
In our study (Table – 12) 56.5% of patients in the negative 
CT findings group & 80% of patients in positive CT group had 
systolic BP of 140 – 160 mm of Hg. Majority in both groups had 
diastolic BP of 90 – 100 mm of Hg. In 44.7% in negative CT group 
& 33.3% in positive CT group had mean arterial pressure 
>126mmof Hg. There was no statistically significant difference 
between the groups in terms of blood pressure parameters.  
 In the study by Chakravarthy et al all patients had BP over 
140mm of  Hg systolic and 100mm of  Hg diastolic.  
In our study (Table-13) Grade–3 hypertensive retinopathy 
fundus changes were seen in 13.3% in positive CT group & none in 
negative CT group with the p value of 0.000 which is statistically 
significant .  88% of patients had normal fundus on examination. 
In the study by Chakravarthy et al all patients had fundus changes.  
  
 
 
In our study (Table -14) 73.3% of patients in the positive CT 
findings group and 30.6% in negative CT findings group had 
proteinuria of 2+. p value is 0.015, thus statistically significant 
difference was observed between the groups.  
In our study (Table-15) 20% of patients in positive CT 
findings group had platelet count less than 1 lakh per mm3. None in 
negative CT group had thrombocytopenia. p value is 0.000, thus 
statistically significant difference was observed between the 
groups.  
 In a study by Hira.B and Moodley [46] 70% had 
thrombocytopenia.  
In our study (Table-16) 20% of patients in positive CT 
findings group and 1.2% in negative CT group had altered liver 
function test. p value is 0.001, thus statistically significant 
difference was observed between the groups.  
In the study by Hira.B and Moodley 7% had altered liver 
function test.  
  
 
 
In our study (Table -17) only 1.2% of patients in negative CT 
findings group & none in positive CT group had renal impairment. 
p value is 0.672, thus there was no statistically significant 
difference.  
In a study by Zhu XW [51] those patients with renal 
impairment and retinal changes were found to be more susceptible 
to cerebral lesions (p<0.05). This was observed by comparative 
study of relationship between either the function of liver or kidney 
and retinal changes with cerebral lesions.   
Our study has also shown that patients with altered liver 
function and retinal changes were more susceptible for cerebral 
lesions.  
In our study (Table-18) only 2 patients were not treated with 
magnesium sulphate regimen because of renal impairment in one 
patient, and because of severe hypotension in another patient. Both 
of them did not have any positive CT finding. 73.3% in positive CT 
finding group and 71.8% in negative CT group were treated with 
standard dose magnesium sulphate regimen.  
  
 
 
But in the study by Chakravarthy et al none were treated with 
magnesium sulphate regimen. All the patients in the study by 
Chakravarthy et al were managed by neurologists and not by 
obstetricians.  
In our study (Table-19) 73.3% of patients in positive CT 
finding group and 35.3% in negative CT group needed 
anticonvulsant phenytoin in addition to MgSO4 regimen for control 
of seizures. p value is 0.006, thus statistically significant difference 
was observed between the groups.  
In the study by Chakravarthy et al all patients were treated 
with intravenous phenytoin.  
In our study (Table-20) out of 15 patients with positive 
findings the most common positive CT scan finding was cerebral 
odema, it was seen in 7 patients (46%). Next common finding was 
cerebral haemorrhage observed in 5 patients (33%). 2 patients 
(13.3%) had cerebral infarction. 1 patient (6%) had an old calcified 
lesion. out of the 7 with cerebral odema in 4 patients the findings 
were suggestive of Posterior Reversible Encephalopathy Syndrome.  
  
 
 
In the study by Chakravarthy et al all 8 patients (100%) had 
cerebral odema, 3 patients (37%) had cerebral haemorrhage.  
In a study by Dejana Jovanovic et al out of 29 patients 83% 
had pathological findings. The most common findings were cerebral 
odema.  
In the study by Milliez et al out of 18 patients with positive 
findings 3 had features of cerebrovascular damage, 6 had cerebral 
odema, 9 had exaggerated cortical sulci suggesting the diagnosis of 
communicating hydrocephalus with cortical atrophy.  
In the study by Moodley et al (1993) most common finding 
was cerebral odema.  In our study also the most common finding 
was cerebral odema. 
 In our study (Table-21) parietal region was the most common 
area affected. 6 patients i.e. 40% had lesion in parietal region. 4 
(26.6%) had diffuse involvement. 2(13.3%) had lesion in fronto-
temporal region. 2(13.3%) had lesion in occipital region. 1(6.6%) 
had lesion in brain stem.  
  
 
 
In the study by Dejana Jovanovic et al [1] occipital and 
parietal regions were the most common affected areas.  
In the study by Chakravarthy et al occipital region was the 
most affected. There was no lesion in brainstem or basal ganglia.  
In a study by Zhu XW cerebral lesions were involved at 
cortical and subcortical area of bilateral parietal and occipital lobes, 
secondly at deep basal ganglia and the superior sagittal sinus.  
In a study by Milliez et al none of the patients had diffuse 
involvement.  
As it has been already discussed the cause for such 
presentation is that acute hypertension would stimulate the 
perivascular sympathetic nerves which would protect the anterior 
but not the poorly innervated posterior circulation.  
In our study (Table -22) all 85(100%) patients who did not 
have any positive findings in CT scan brain recovered completely. 
whereas in the positive CT findings group only 7 (46.7%) patients 
recovered completely, 1(6.7%) patient recovered with hemiparesis 
  
 
 
& 7(46.7%) patients expired. p value is 0.000, thus statistically 
significant difference was noted between the groups.  
In the study by Chakravarthy et al all patients recovered fully. 
In the study by Milliez et al 3 (16%) out of 18 patients expired, 
remaining 15 recovered fully. In a study by Hira.B and Moodley 
out of 30 patients 15(50%) died, 10(33%) recovered, 2(7%) had 
paresis, 3(10%) had psychosis.   
In our study (Table-23) when we compared the maternal 
outcome with the type of CT scan changes we found that all 
5(100%) patients who had haemorrhagic lesion had expired. Out of 
7 patients with cerebral odema 6(85.7%) recovered & 1(14.2%) 
patient whose lesion was suggestive of PRES expired. In the 2 
patients with cerebral infarction, 1(50%) recovered with 
hemiparesis & 1(50%) expired. 1 patient who had a calcified lesion 
also recovered fully. p value is <0.05, thus statistically significant 
difference was noted between the groups.  
In the study by Milliez et al all 6 patients with cerebral 
odema recovered, all 9 patients with not related findings also 
recovered, all 3 patients who had features of cerebrovascular 
  
 
 
damage, a total middle cerebral artery thrombosis, a massive 
Intraventricular haemorrhage, a temperoparietal hematoma expired.  
In our study (Table-24) when we compared the maternal 
outcome with areas of brain affected all 4 (100%) patients who had 
diffuse involvement recovered. All 2(100%) patients who had 
frontotemporal region involvement expired. Of the 6 patients with 
parietal region involvement 2(33.3%) patients recovered, 1(16.7%) 
recovered with hemiparesis, 3(50%) patients expired. Of the 2 
patients with occipital region involvement, 1(50%) recovered, 
1(50%) expired. The 1 (100%) patient with brainstem involvement 
expired. P=0.000 thus statistically significant difference was noted 
between the groups.  
In our study (Table-25) when the alive patients with positive 
CT findings were followed up, out of the 8 alive patients, lesion 
disappeared in 6(75%) patients. All the 6 were the patients who 
earlier had cerebral odema. In 1(12.5%) patient the lesion persisted. 
That was the patient with old calcified lesion. 1(12.5%) patient lost 
follow up. That was the patient with infarct in left frontoparietal 
region who recovered with hemiparesis.  
  
 
 
In the study by Chakravarthy et al out of 8, 7 patients had 
follow up. In all except 1 patient the lesions detected earlier 
resolved completely. It included both cerebral odema and 
haemorrhage. In 1 patient with pontine lesion, the lesion persisted 
suggesting it to be an infarct or a post hemorrhagic gliotic area.  
In the study by Dejana Jovanovic et al all patients who had 
cerebral odema resolved or regressed in two weeks follow up.  
  
 
 
SUMMARY 
100 patients with eclampsia between August 2008 to August 
2009 at the Institute of Obstetrics and Gynaecology, Madras 
Medical College, Chennai were selected according to the inclusion 
and exclusion criteria already stated in the methodology were taken 
for this prospective descriptive study.  
Computed Tomography scan of brain was done for these 
patients within 1 week of postpartum period. Patients with positive 
CT findings were followed up at 1 to 2 months interval.  
The results obtained were tabulated, analysed and 
summarised as follows.  
1. Out of the 100 patients 15% had pathological findings 
in the Computed Tomography scan of brain taken.  
2. Majority of the patients (78%) were in the age group of 
20-30 yrs.  
3. Majority of the patients (68%) were primigravida.  
  
 
 
4. Majority of the patients (69%) had normal body mass 
index of 19.8 - 26.  
5. Most of patients around 70% were in the antepartum 
period at the time of presentation.  
6. Majority of the patients (75%) had diagnosed 
hypertension only at the time of presentation.  
7. Most of the patients (73%) had imminent symptoms.  
8. Most of the patients (69%) had antepartum eclampsia.  
9. Only in positive CT finding group 13.3% had past 
history of either eclampsia or thrombocytopenia.           
p value is 0.04 hence statistically significant.  
10. Only in positive CT finding group 33.3% were 
unconscious at the time of presentation. p value is        
0. 000, hence statistically significant.  
11. Most common blood pressure was systolic 140-160mm 
of Hg in around 60% and diastolic 90-100mm of Hg in 
both groups.  
  
 
 
12. Only in the positive CT finding group 13.3% had 
Grade–3 hypertensive retinopathy changes. p value is 
0.000, hence statistically significant.  
13. All patients had proteinuria. In the positive CT findings 
group 73.3% had proteinuria of 2+. p value is 0.015, 
hence statistically significant.   
14. Only in the positive CT findings group 20% had 
thrombocytopenia. p value is 0.000, hence statistically 
significant.  
15. 20% of patients in positive CT findings group had 
altered liver function test. p value is 0.001, hence 
statistically significant 
16. Cerebral odema 46% was the most common positive CT 
finding. Parietal region 40% was the most common area 
of the brain affected.  
17. Maternal mortality was high 46.7% in the positive CT 
finding group. p value is 0.000, hence statistically 
significant.  
  
 
 
18. 85.7% of patients with cerebral odema recovered and in 
all of them the lesion resolved completely. 100% of 
patients with cerebral haemorrhage expired.   
19. 100% of patients with diffuse involvement recovered. 
100% of patients with frontotemporal or brainstem 
involvement expired. p value is 0.000 hence statistically 
significant.  
  
 
 
 CONCLUSION  
1. 15% of patients with eclampsia had pathological 
abnormalities of brain detected through Computed 
Tomography scan of brain.  
2. Maternal mortality was high in patients with positive 
CT scan brain findings.  
3. Patients with altered liver function, retinal changes, and 
thrombocytopenia are more prone for developing 
cerebral lesions.  
4. Cerebral odema was the most common pathological 
abnormality detected. In all but one of these patients 
recovery and resolving of the lesions were complete.  
5. Maternal mortality was high in patients with cerebral 
haemorrhage, involvement of frontotemporal region or 
brainstem region. Hence prognosis in these patients is 
poor.  
  
 
 
6. Since majority of patients had hypertension diagnosed 
only at the time of presentation the need for effective 
screening of hypertension and its management is 
emphasised.  
7. Thus it is emphasised that CT scan of brain should be 
included in the investigation protocol for eclampsia if 
not for all at least for those patients with complications.  
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NAME: 
AGE:                                      REGISTER NO: 
ADDRESS:                                 SOCIOECONOMIC STATUS: 
 
DATE OF ADMISSION: 
BOOKED/UNBOOKED:                       HEIGHT:         WEIGHT: 
PARITY: 
GESTATIONAL AGE/POSTPARTUM: 
HYPERTENSION DIAGNOSED AT: 
IMMINENT SYMPTOMS:                  YES           NO 
             Headache 
             Vomiting 
             Blurring of vision 
             Epigastric pain 
             Oliguria 
 
NUMBER OF SEIZURES 
  
 
 
                    Antepartum 
                      Intrapartum 
                      Postpartum 
PAST HISTORY: Hypertension 
                            Preeclampsia 
                            Eclampsia 
                            Thrombocytopenia 
CONSCOUS LEVEL: Conscious 
                                   Drowsy      
                                   Unconscious 
BLOOD PRESSURE:           SYSTOLIC     DIASTOLIC     MAP 
    At admission 
    Maximum BP 
FUNDUS EXAMINATION:    NORMAL    ABNORMAL 
URINE ALBUMIN: 
HB% 
PCV% 
PLATELETS: 
  
 
 
RENAL FUNCTION TEST: Normal 
                      Abnormal 
LIVER FUNCTION TEST: Normal 
                     Abnormal 
MAGNESIUM SULPHATE THERAPY: 
ANTICONVULSANT: 
CT SCAN FINDINGS: 
PATIENT’S CONDITION: 
                       Recovered 
                       Recovered with sequelae 
                       Expired 
FOLLOW UP: 
                        
 
 
 
 
  
 
 
                                   ABBREVIATION 
ALT – Alanine transaminase  
AST – Aspartate aminotransferase 
BBB – Blood brain barrier 
BMI – Body mass index 
CNS – Central nervous system 
CT SCAN – Computerised Tomographic Scan 
DIC – Disseminated intravascular coagulation 
DWI – Diffusion weighted imaging 
FLAIR – Fluid attenuation inversion recovery 
GA – Gestational age 
HT – Hypertension  
LDH – Lactate dehydrogenase 
  
 
 
MgSo4 – Magnesium sulphate 
MRI – Magnetic Resonance Imaging 
NO – Nitric oxide 
NOS – Nitric oxide synthase 
PRES – Posterior Reversible Encephalopathy syndrome 
SLE – Systemic Lupus Erythematosus 
SPECT – Single photon emission computed tomography 
TNF – Tumour necrosis factor 
VCAM – Vascular Cell Adhesion Molecule 
 
 
 
 
  
 
 
KEY TO MASTER CHART 
AP – Antepartum 
BMI – Body mass index 
PRIMI – Primigravida 
GA – Gestational age 
PP – Postpartum 
H – Headache 
V – Vomiting 
E – Epigastric pain 
B – Blurring of vision 
C – Conscious 
D – Drowsy 
UC – Unconscious 
MAX BP – Maximum Blood pressure 
MAP – Mean arterial pressure 
  
 
 
FUNDUS – Fundus changes 
N – Normal 
GRADE – Grading of hypertensive retinopathy 
U.ALB – Urine albumin 
HB% - Haemoglobin percentage 
LFT – Liver function test 
RFT – Renal function test 
AN – Abnormal 
MGSO4 – Magnesium sulphate regimen 
LD – Low dose regimen 
SD – Standard dose regimen 
MGSO4 IN – Magnesium sulphate infusion 
NO – Magnesium sulphate regimen not given 
 P – Phenytoin 
  
 
 
AN-1 –  Haemorrhage in right frontal & subarchanoid 
haemorrhage 
AN-2 –  Subacute infarct in left fronto-parietal region 
AN-3 –  Haemorrhage in parietal region 
AN-4 –  Brainstem haemorrhage  
AN-5 –  Haemorrhagic infarct in left parietal region 
AN-6 –  Hypodensity in bilateral high parietal region ? 
venous infarct  
AN-7 –  Old calcified lesion seen in right high parietal region 
AN-8 –  Left fronto temporal intracerebral haemorrhage with 
intraventricular extension with mass  
              effect 
AN-9 –  Diffuse cerebral odema 
AN-10 –  Hypodensity in right post parietal region ? 
PRES(Posterior reversible encephalopathy 
                 Syndrome) 
  
 
 
AN-11 –  shows white matter hypodensity suggestive of 
PRES 
AN-12 –  Features suggestive of diffuse cerebral odema 
AN-13 –  Diffuse cerebral odema 
AN-14 –  White matter hypodensity over periventricular 
region & post region suggestive of PRES 
AN-15 –  Bilateral occipital lobe hypodensity suggestive of 
PRES 
R – Recovered 
E – Expired 
R-S – Recovered with sequelae 
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CT SCAN PICTURES OF PATHILOGICAL CHANGES OF BRAIN IN ECLAMPSIA 
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SN NO AGE      BMI PARITY     GA/PP    HT AT
SYMPTO
M 
SEIZURE PAST H/O
CONSCIOUS 
LEVEL
MAX BP     MAP FUNDUS
1 20 22.8 primi 38 38 H & V 1/AP No C 160/120 113 N
2 18 22.6 primi 35 35 H 5/AP No D 140/110 120 N
3 25 20 primi 30 30 V 3/AP No C 200/120 146 N
4 25 21.6 G3P2L1 36 36 V&E 3/AP No C 170/130 143 N
5 35 32 G2P1L1 35 35 H&B&V 3/AP1/PP NO C 150/96 114 N
6 27 21 P2L2 PP 39 NO 3/PP NO D 160/110 126 N
7 27 21.7 P1L1 PP PP NO 3/PP NO C 140/100 113 N
8 24 22 P1L1 PP 28 NO 1/PP No C 130/90 103 N
9 30 22.2 G2A1 29 29 H&B 2/AP NO C 200/120 146 Grade‐1
10 36 27.1 P3L3 PP 39 E 1/PP No UC 170/110 130 Grade‐3
11 21 23.4 primi 30 30 H&B 1/AP1/PP No D 200/140 160 N
12 18 24.6 P1L0 PP PP NO 3/PP No D 150/120 130 N
13 23 27.4 primi 24 24 H 15/AP No D 180/120 140 N
14 23 24.6 primi 35 35 H 3/AP No C 170/120 136 N
15 20 27.2 P1L1 PP PP H 3/PP No C 140/100 116 N
16 24 21.54 primi 30 30 NO 5/AP No C 140/100 116 N
17 20 23.3 primi 40 40 V 1/AP No C 170/140 150 N
18 35 26.6 P2L2 PP 38 H&B 1/PP No D 160/110 126 N
19 22 22.8 primi 39 39 H 2/AP No C 160/100 120 N
20 23 32.4 primi 39 32 H 1/AP No C 180/120 140 N
21 19 18.6 P1L1 35 35 NO 1/PP No C 150/90 110 N
22 18 21 primi 28 28 H&V 5/AP No C 160/110 126 Grade‐1
23 23 22.9 P2L2 39 38 H 1/PP No C 160/110 126 N
24 20 23.8 G2P1L1 36 32 B 1/AP5/PP No D 150/120 130 N
25 42 28.8 G2A1 21 21 H&B 3/AP No D 170/110 130 N
26 28 20 G2P1L1 29 29 H&V 3/AP No C 150/100 116 N
27 20 30.5 P1L1 PP 37 NO 1/PP No c 160/110 126 Grade‐1
28 23 25.3 primi 32 32 NO 2/AP No C 160/100 130 N
29 24 22 P1L1 PP PP H 2/PP No C 150/100 116 N
30 25 24.8 primi 38 37 H 2/AP No C 150/100 116 N
31 23 23.8 primi 29 29 NO 2/AP No D 150/100 110 N
32 19 32.5 P1L1 38 38 NO 1/PP No C 140/100 113 N
33 24 19.7 G2P1L1 34 34 H&V&B 2/AP No C 170/110 130 Grade‐1
34 26 24.7 G4P3L3 28 28 H 1/AP No C 160/120 133 N
35 25 24.5 P1L1 PP PP NO 5/PP No UC 160/100 120 N
36 24 32.3 G2P1L1 40 40 NO 1/AP No C 130/100 110 N
37 25 28.9 G2P1L0 PP 24 H 1/PP ITP UC 160/100 120 N
38 35 22.2 P1L0A3 PP 36 H 1/PP No C 160/110 126 N
39 18 20.9 primi 37 36 H 2/AP No C 180/120 140 N
40 24 20.3 P3L2 PP PP H 3/PP E D 150/100 116 N
41 28 23.8 G3P2L2 31 31 H&V 1/AP No C 170/120 136 N
42 24 25.1 G2P1L1 36 36 H 1/AP No C 180/120 150 N
43 24 17.3 primi 37 37 H&v&B 3/AP No C 140/100 116 N
44 30 27.3 P3L3 PP PP H 2/PP No D 140/100 116 N
45 20 24.2 primi 38 37 H&V 1/AP No C 180/110 133 N
46 18 25.7 primi 39 39 H&B&E 1/AP No C 170/110 130 Grade‐1
47 20 25.1 primi 39 39 NO 2/AP No D 160/110 126 N
48 20 31.1 primi 32 32 H 2/AP No D 180/120 140 N
49 25 25.6 primi 30 28 B 5/AP No C 160/120 133 N
50 22 25.3 P2L2 PP 37 H 1/PP No C 140/110 126 N
51 19 31.1 primi 37 37 H 1/AP No C 180/110 133 N
52 19 21.4 primi 30 30 NO 2/AP No D 160/100 120 N
53 26 22.7 P2L2 PP PP NO 1/PP No C 150/90 110 N
54 23 22.2 P1L1 PP PP H 2/PP No C 160/100 120 N
55 25 24 primi 39 39 H 1/AP No C 190/130 150 N
56 22 22.8 primi pp pp NO 1/pp No C 160/100 120 N
57 27 26.5 G2P1L1 38 38 H&V 6/AP No C 160/110 126 N
58 25 31.1 primi 30 30 H 3/AP No C 160/100 120 N
59 23 26.6 G3P2L1 39 39 NO 3/AP AP/PP C 140/90 116 N
60 36 22.2 P1L1A1 PP 34 H 1/PP No C 170/120 136 N
61 18 25.3 P1L1 PP PP NO 3/PP No C 150/100 126 N
62 20 22.4 primi 27 27 H 8/AP No D 180/120 140 N
63 22 21.6 primi 35 35 H 3/AP No C 190/100 130 N
64 21 24.6 P2L2 PP 35 H 1/PP No C 150/90 106 N
65 23 28 primi 34 34 H 4/AP No C 170/110 133 N
66 22 22.2 primi 35 24 H&B 1/AP No C 160/110 130 N
67 28 31.2 P1L1 PP 39 H 1/PP No C 140/100 113 N
68 20 21.3 primi 38 38 H&V 1/AP No C 140/110 123 N
69 28 23.1 P1L1 40 40 NO 1/PP No C 160/100 120 N
70 34 24.8 primi 24 24 H 5/AP No UC 180/130 146 Grade‐3
71 19 30.4 primi 38 38 H 4/AP No C 150/100 126 N
72 25 23.8 G2P1L0 35 35 NO 1/AP AP C 150/100 116 N
73 22 25 P1L1 PP 28 H 1/PP No C 170/130 140 Grade‐1
74 18 22 primi 36 36 NO 1/AP No C 150/100 116 N
75 20 27 primi 36 28 H&V 5/AP No D 210/120 150 N
76 17 20.5 primi 31 30 v 1/AP2/PP No C 140/110 126 N
77 20 22.7 primi 39 39 H&V 3/AP1/PP No C 170/110 123 N
78 23 24 G2P1L1 36 36 H&B 3/AP No C 180/110 133 N
79 21 25.9 primi 35 34 H&V 3/AP No C 150/100 126 N
80 20 27.5 primi 36 36 H 2/AP No C 150/90 110 N
81 22 20.7 P1L1 PP PP H 1/PP No C 150/110 123 N
82 22 24.2 primi 40 40 H&E 2/AP No C 160/100 120 N
83 22 22 primi 29 29 H&E 3/AP No C 170/100 130 N
84 20 22.8 P1L1 PP PP NO 2/PP No C 180/110 133 N
85 22 20.3 primi 36 36 H 2/AP No C 180/130 146 Grade‐2
86 22 26.5 primi 21 21 H&E 1/AP No C 140/100 113 Grade‐2
87 21 23.8 primi 36 36 H&B&V 2/AP No D 150/110 126 Grade‐2
88 28 19.4 G3A2 37 37 NO 1/AP No C 180/120 140 Grade‐2
89 32 28.8 primi 29 29 H&B 3/AP No C 170/110 130 Grade‐2
90 21 25.3 primi 34 34 NO 2/AP No C 130/110 116 Grade‐2
91 27 26.8 primi 30 30 H&V&B 5/AP No D 200/150 166 Grade‐2
92 23 21.6 P1L0 PP 28 H&V 2/PP No C 150/100 116 N
93 30 25.6 primi 33 33 H 3/AP No D 160/110 130 N
94 22 21.2 P1L1 PP 37 NO 1/PP No C 150/90 110 PP CAT
95 19 24 primi 35 35 NO 2/AP No C 160/100 120 Grade‐2
96 22 27.3 G3P1L1 30 30 H&B&V 2/AP No C 190/130 150 Grade‐1
97 27 25 G3P1L0 30 30 H&V 1/AP No C 170/110 130 N
98 20 20 G2A1 32 32 H 6/AP No D 150/110 123 N
99 20 20 primi 36 36 V 10/AP No UC 140/100 113 N
100 25 27 G2P1L0 33 33 NO 2/AP No C 170/110 130 N
U.ALB   HB% PLATELET       LFT RFT MGSO4 ANTI CON CTFINDING RECOVERY
4 9 2 N N L D No N R
3 10 1.5 N N L D P N R
3 6.5 1.8 N N S D No N R
3 10 1.7 AN N L D No N R
4 12.5 1 N N S D NO N R
1 9.5 1.8 N N L D NO N R
1 9.5 1.6 N N L D P N R
2 9 1.5 N N S D NO N R
3 9.8 1.5 N N S D No N R
2 6 1 AN N L D P AN‐1 E
4 9.8 1.5 N N L D P N R
3 11 2 N N L D P N R
4 8 2.1 N AN L D P N R
4 8 1.4 N N S D No N R
4 9 2.2 N N L D P N R
4 11.5 1.6 N N L D No N R
2 10.5 2.5 N N L D No N R
1 10.5 1.8 N N L D No N R
2 9 1.5 N N S D No N R
1 10.5 1.8 N N L D No N R
1 10.5 2 N N S D No N R
3 10 1.6 N N S D No N R
1 11 1.1 N N S D P N R
1 12.5 1.6 N N S D P N R
1 9.5 2 N N S D P N R
2 11 2.3 N N S D No N R
1 9.5 1.7 N N S D No N R
1 10 2.4 N N S D No N R
1 9 2.8 N N S D P N R
1 11 1.8 N N S D No N R
4 9 1.3 N N S D No N R
1 9 1.5 N N L D No N R
3 7.5 1.6 N N S D No N R
2 9 1.4 N N L D P AN‐2 R‐S
1 10 1.1 AN N S D P AN‐3 E
1 10 1.3 N N S D P N R
2 9 0.7 N N MGSO4 I P AN‐4 E
1 10 1.6 N N S D P N R
3 8 2 N N L D P N R
2 12 1.9 N N S D P AN‐5 E
3 9 2.4 N N NO P N R
1 9 1.2 N N S D No N R
2 12 1.5 N N S D P N R
1 9 2 N N S D P N R
1 8.5 2.3 N N S D No N R
1 9 1.5 N N S D No N R
1 9 1.65 N N L D No N R
2 9 1.8 N N S D No N R
2 9 1.9 N N S D No N R
2 10 2.1 N N S D No N R
4 10 2.3 N N S D No N R
2 9.5 0.92 N N S D P AN‐6 E
1 9 1.8 N N S D P N R
1 7.5 1.58 N N L D No N R
3 11 1.37 N N S D No N R
1 9.5 1.6 N N S D P AN‐7 R
2 9 1.8 N N S D P N R
1 10.5 1.5 N N L D No N R
1 9.5 2 N N S D No N R
2 7 1.5 N N S D P N R
1 11 1.5 N N NO P N R
2 8 2.2 N N S D No N R
1 10 1.6 N N L D P N R
2 10 1.8 N N L D No N R
1 9 1.5 N N L D No N R
2 10 1.7 N N S D No N R
2 9 1.8 N N L D No N R
1 10 1.7 N N S D No N R
1 10 1.6 N N S D P N R
2 9.5 2 N N S D P AN‐8 E
3 9 1.7 N N S D No N R
2 10 1.6 N N S D No N R
3 10 1.8 N N S D No N R
1 9 2 N N S D No N R
3 11.5 2.1 N N S D No N R
2 9 1.8 N N S  D&L D P N R
2 9 1.3 N N  S D P N R
2 9 2 N N S D No N R
1 9.5 1.6 N N S D No AN‐9 R
3 9 1.6 N N S D No N R
1 8.6 1.8 N N S D P N R
1 8 2.1 N N S D P N R
2 9 1.8 N N S D P N R
2 8.5 1.4 N N S D No N R
4 9.5 1.8 N N S D No N R
2 9 1.4 N N S D No N R
2 8.5 3 N N S D No N R
1 8.5 1.4 N N S D No N R
3 11 1.5 N N S D No N R
2 9.5 1.4 N N S D No N R
2 9.5 2.6 N N S D P N R
2 9 2 N N S D P AN‐10 R
3 10.6 1.1 N N S D No AN‐11 R
2 9 4 N N S D P AN‐12 R
2 8.5 1.6 N N S D No AN‐13 R
4 9.5 1.15 N N S D No N R
2 11 0.37 AN N MGSO4 IN No AN‐14 E
2 9 1.6 N N S D P N R
2 9 1.4 N N S D P AN‐15 R
2 9 1.3 N N S D P N R
